|Articles|May 1, 1999

May 1999
Volume 5
Issue 5

Assessment of Patient Satisfaction with a Formulary Switch from Omeprazole to Lansoprazole in Gastroesophageal Reflux Disease Maintenance Therapy

Author(s)Laura J. Condra, PharmD, Anthony P. Morreale, PharmD, BCPS, MBA, Stephen N. Stolley, PharmD, BCPS

Download PDF: Assessment of Patient Satisfaction with a Formulary Switch from Omeprazole to Lansoprazole in Gastroesophageal Reflux Disease Maintenance Therapy

Articles in this issue

over 26 years ago

Article

Relationship between Primary Payer and Use of Proactive Immunization Practices: A National Survey

over 26 years ago

Article

Polypharmacy Management in Medicare Managed Care: Changes in Prescribing by Primary Care Physicians Resulting from a Program Promoting Medication Reviews

over 26 years ago

Article

Course and Cost of Treatment for Depression with Fluoxetine, Paroxetine, and Sertraline

over 26 years ago

Article

Project LEAP of New Jersey: Lower Extremity Amputation Prevention in Persons with Type 2 Diabetes

over 26 years ago

Article

Quality of Care for Chronic Illness in Primary Care: Opportunities for Improvement in Process and Outcome Measures

over 26 years ago

Article

Overview of Platelet Glycoprotein IIb/IIIa Receptor Antagonist Treatment in the Management of Coronary Interventions and Acute Ischemic Coronary Syndromes

over 26 years ago

Article

Benign Prostatic Hyperplasia: An Overview for Pharmacists

over 26 years ago

Article

Correspondence regarding, "How Should Managed Care Treat Onychomycosis?"

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

ByBimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Miranda R. Polin, MS, BS,Irl B. Hirsch, MD,Laya Ekhlaspour, MD,Steve Edelman, MD,Diana I. Brixner, PhD, RPh,Charles Stemple, DO

December 22nd 2025

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

ByPamela S. Roberts, PhD, OTR/L,Chih-Ying Li, PhD, OTR/L,Debra S. Ouellette, MS, OTR/L,Nabeel Qureshi, MPH,Erica Spivack, MHA,Mary Nasmyth, MD,Nancy L. Sicotte, MD,Zaldy S. Tan, MD

December 22nd 2025

Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures

ByJoshua R. Vest, PhD, MPH,Christopher A. Harle, PhD,Justin Blackburn, PhD

December 19th 2025

Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Katarzyna Rodchenko, MA, MPH,Lauren Isenman, MPH,Xue Han, PhD,Deborah Freedman, MBA,Rashmi Patel, MD, PhD

December 17th 2025

Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy

ByGury K. Doshi, MD,Lucio Gordan, MD,Kirollos Hanna, PharmD,Scott Freeswick, PharmD,Natalie Dickson, MD,Desi Kotis, PharmD,Osama Abdelghany, PharmD, MHA,Ken Komorny, PharmD,Neal Dave, PharmD,Michael Reff, RPh, MBA

December 16th 2025

Assessment of Patient Satisfaction with a Formulary Switch from Omeprazole to Lansoprazole in Gastroesophageal Reflux Disease Maintenance Therapy

Articles in this issue

Newsletter

Related Content

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures

Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes

Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy

Trending on AJMC

ICYMI: Highlights From ASH 2025

Top 5 Most-Read HIV Articles of 2025

The Top 5 Most-Read Multiple Myeloma Content of 2025

Top 5 Most-Read Reimbursement Content of 2025

Top 5 Most-Read Dermatology Content of 2025